Correction: A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice
Natalia E. Cortez(University of Turin), Gerardo G. Mackenzie(University of California, Davis), Brian V. Hong(University of California, Davis), Jihao Xu(University of California, Davis), David Vauzour(University of East Anglia), Chang‐Il Hwang(Institute of Molecular Genetics), Payam Vahmani(University of California, Davis), Matthew G. Pontifex(University of East Anglia), Fangyi Wang(University of California, Davis), Daiwen Chen(Sichuan Agricultural University), Michael Müller(University of East Anglia), Karen Matsukuma(Sacramento City College), Jon J. Ramsey(University of California, Davis), Cecilia Rodríguez Lanzi(Universidad de Ciencias Medicas)
Cited by 1
Related Papers
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Simvastatin Reduces Expression of Cytokines Interleukin-6, Interleukin-8, and Monocyte Chemoattractant Protein-1 in Circulating Monocytes From Hypercholesterolemic Patients
|Arteriosclerosis Thrombosis and Vascular Biology|2002|377
Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain
|Microbiome|2022|352
The microbiota–gut–brain axis: pathways to better brain health. Perspectives on what we know, what we need to investigate and how to put knowledge into practice
|Cellular and Molecular Life Sciences|2022|232